NEW: World Trade TARIFFS Simulator!
NEW: 2023 Data and Complexity Rankings
Sign In
Pricing

2023
Exports $2.16BWorld Rnk 2 / 190
Flag Rnk 141 / 1217
2023
Destination $55.2M Belgium
2022 - 2023
FASTEST GROWING MARKET $55.2MNetherlands
2023
PRODUCT COMPLEXITY IN Special Pharmaceuticals0.53Rnk 356 / 1025
2023
Imports $3.5BWorld Rnk 1 / 220
Flag Rnk 146 / 1215
2023
Origin $91.8M Germany
2022 - 2023
FASTEST GROWING ORIGIN $91.8MGermany
2023
ECONOMIC COMPLEXITY of United States1.5Rnk 10 / 132

About

Exports In 2023, United States exported $2.16B in Special Pharmaceuticals, making it the 2nd largest exporter of Special Pharmaceuticals in the world. At the same year, Special Pharmaceuticals was the 141st most exported product in United States. The main destination of Special Pharmaceuticals exports from United States are: Belgium ($350M), China ($270M), Germany ($163M), Japan ($148M), and Singapore ($128M).

The fastest growing export markets for Special Pharmaceuticals of United States between 2022 and 2023 were Netherlands ($55.2M), Belgium ($33.2M), and China ($20.5M).

Imports In 2023, United States imported $3.5B in Special Pharmaceuticals, becoming the 1st largest importer of Special Pharmaceuticals in the world. At the same year, Special Pharmaceuticals was the 146th most imported product in United States. United States imports Special Pharmaceuticals primarily from: Germany ($528M), Finland ($447M), Netherlands ($439M), Norway ($337M), and Ireland ($241M).

The fastest growing import markets in Special Pharmaceuticals for United States between 2022 and 2023 were Germany ($91.8M), Canada ($66.9M), and Sweden ($26M).

COMPANIES In 2023, leading companies such as One Banana (24), Stihl (20), and Amazon (18) were at the forefront of shipping Special Pharmaceuticals to the United States.

Latest Trends

November 2024

About

Overview In November 2024 United States' Special Pharmaceuticals exports accounted up to $205M and imports accounted up to $257M, resulting in a negative trade balance of $51.5M. Between November 2023 and November 2024 the exports of United States'   Special Pharmaceuticals have decreased by $-1.99M (-0.96%) from $207M to $205M, while imports decreased by $-75.8M (-22.8%) from $333M to $257M.

Destinations In November 2024, Special Pharmaceuticals were exported mostly to China ($32.8M), Japan ($24.4M), Canada ($16.7M), Belgium ($16.3M), and Germany ($15M), and were imported mostly from Germany ($33M), Norway ($32.3M), Italy ($22.7M), Denmark ($22.1M), and Canada ($19.6M).

Growth In November 2024, the decrease in Special Pharmaceuticals's year-by-year exports was explained primarily by a decrease in exports to China ($-6.28M or -16.7%), Japan ($-2.91M or -11.2%), and Italy ($-1.77M or -52.7%). In November 2024, the decrease in Special Pharmaceuticals's year-by-year imports was explained primarily by a decrease in imports from Netherlands ($-25.5M or -27.9%), Mexico ($-18.5M or -70.4%), and Denmark ($-10.3M or -50.4%).

Subnational Monthly Trade

Time Scale
Flow
Color
EXPORT GROWTH (November 2023 - November 2024)$-1.99M(-0.96%)
IMPORT GROWTH (November 2023 - November 2024)$-75.8M(-22.8%)
MAIN EXPORTER (November 2024)Tennessee$80M
MAIN DESTINATION (November 2024)China$32.8M

This section shows Special Pharmaceuticals's exports and imports data at subnational level for United States. Click any date in the line plot, any subnational region in the geomap, or any destination or origin country to explore the exports or imports behavior of Special Pharmaceuticals over time.

For full datasets download visit Bulk Download page.

Go to Bulk Download

Subscribe today to OEC pro and access the latest data

Sign Up

Subscribe today to OEC pro and access the latest data

Sign Up

Subscribe today to OEC pro and access the latest data

Sign Up

Historical Data

Trade Balance

Color
EXPORTS (2023)$2.16B
IMPORTS (2023)$3.5B
NET TRADE (2023)-$1.33B

In 2023, United States exported $2.16B in Special Pharmaceuticals. The main destinations of United States exports on Special Pharmaceuticals were Belgium ($350M), China ($270M), Germany ($163M), Japan ($148M), and Singapore ($128M).

In 2023, United States imported $3.5B in Special Pharmaceuticals, mainly from Germany ($528M), Finland ($447M), Netherlands ($439M), Norway ($337M), and Ireland ($241M).

Explore Visualizations

Export Destinations (2023)

Import Origins (2023)

Market Growth

Flow
THE FASTEST GROWING Special Pharmaceuticals EXPORT MARKETS FOR United States WERE (2022 - 2023):
Netherlands$55.2M (115%)
Belgium$33.2M (10.5%)
China$20.5M (8.21%)
THE FASTEST DECLINING MARKETS FOR THE EXPORT OF Special Pharmaceuticals BY United States WERE (2022 - 2023):
Singapore-$37.3M (-22.6%)
Japan-$19.1M (-11.4%)
Switzerland-$7.81M (-13.9%)
Explore Visualizations

Change in Exports by Market (2022 - 2023)

Market Concentration

View
Flow
Type
In 2023, United States's main exporting competitors in Special Pharmaceuticals were:
Germany $3.28B
Netherlands $1.28B
In 2023, United States's main importing competitors in Special Pharmaceuticals were:
China $1.3B
Germany $1.2B

Explore Visualizations

Trade Value of Special Pharmaceuticals by Exporters

Potential Exports

Potential Exports

Flow
View
TOP EXPORT POTENTIALCanada+ $45.4M
TOP IMPORT POTENTIALMexico+ $77.6M

Special Pharmaceuticals’s highest export potential is Canada. With an export gap of $45.4M.   Special Pharmaceuticals’s highest import potential is Mexico with an import gap of $77.6M.

See methodology.

Subscribe today to OEC pro and access the latest data

Sign Up

Keep Exploring

Have questions, comments, or concerns?
Send us an e-mail: support@oec.world
Follow @OECtoday on
Created, Designed, and Developed by:
In collaboration with
About the OECPrivacy PolicyTerms